A New Window into Canada’s Pulse Quality

Nov 28, 2025

We've recently launched the Pulse Quality Dashboard — a new resource that makes Canada’s investment in pulse quality research accessible and interactive.

The dashboard brings together years of data showing how genetics and environment influence the quality and nutritional attributes of Canadian peas, lentils, and faba beans. Designed for food industry professionals, researchers, and stakeholders across the value chain, this tool provides a clear view into what makes Canadian pulses a leader in global markets.

With the Pulse Quality Dashboard, you can:

Explore detailed datasets from 2019–2023 across peas, lentils, and faba beans
Understand typical ranges for key compositional and functional attributes
Track variety acreage over time, nationally and by province
Canada’s continued investment in pulse research keeps our industry at the forefront of quality, innovation, and transparency. The Pulse Quality Dashboard represents another step forward in making Canada’s pulse quality data open and actionable.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.